BENJAMIN GIARMO: Open Payments
NPI 1457766594 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,608 in 210 payments from 18 companies in 2025. Trend: 2023 $4,555 · 2024 $3,501 · 2025 $3,608
Food & beverage: $3,418Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 76 | $1,039 |
| UCB, Inc. | 29 | $569 |
| ABBVIE INC. | 40 | $465 |
| GENZYME CORPORATION | 11 | $286 |
| Galderma Laboratories, L.P. | 8 | $251 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $205 |
| Organon LLC | 7 | $124 |
| LEO Pharma Inc. | 4 | $93 |
| Mallinckrodt Hospital Products Inc. | 3 | $86 |
| Incyte Corporation | 3 | $85 |
Products named: TREMFYA, Bimzelx, SKYRIZI, DUPIXENT, NEMLUVIO, ILUMYA, RINVOQ, ACTHAR.
Industry payments across IN — which companies pay providers there.
